Neuralink Launches N1 Consumer Brain-Computer Interface Headset at $399

Neuralink Launches N1 Consumer Brain-Computer Interface Headset at $399

On November 28, 2027, Neuralink held a product launch event at its Austin headquarters to unveil the N1 — its first consumer-facing brain-computer interface (BCI) device. Priced at $399, the non-invasive device takes the form of an over-ear headset with a behind-the-ear patch, marking the official transition of BCI technology from clinical settings into the consumer electronics market.

From Implant to Wearable: A Fundamental Pivot

The N1 follows a completely different technical approach from Neuralink's earlier implantable chip. It captures brain signals via a high-density dry electrode array (128 channels) positioned over the temporal bone behind the ear, paired with Neuralink's proprietary N2 neural decoding chip for on-device signal processing. Built on TSMC's 3nm process, the N2 integrates a dedicated neural processing unit (NPU) and achieves latency under 12 milliseconds.

"We spent six years solving a core problem: how to obtain neural signals of sufficient quality without opening the skull," said Dongjin Seo, Neuralink's VP of Engineering, at the launch. "The N1's answer is 128-channel dry electrodes combined with adaptive noise-cancellation algorithms, achieving 87% of the accuracy of our implantable solution for motor intent recognition."

The device weighs just 28 grams and offers approximately 14 hours of battery life, charging via a magnetic dock. Connectivity includes Bluetooth 5.4 and Wi-Fi 7, enabling pairing with smartphones, PCs, and VR headsets.

Core Capabilities: Thought Control and Emotional Awareness

The N1 ships with three headline features.

First is Neural Touch — a thought-control system that lets users move cursors, navigate menus, and perform basic gestures by imagining hand movements. Neuralink demonstrated the N1 controlling a MacBook and iPhone, with cursor movement latency of roughly 180 milliseconds. While not as precise as a mouse, it's sufficient for everyday browsing and basic productivity tasks.

Second is MindSense, an emotion-monitoring feature. The N1 analyzes brainwave patterns in real time to identify six emotional states — focus, relaxation, anxiety, fatigue, and others — syncing data with Apple Health and Google Health Connect. Neuralink reports 82% emotion-recognition accuracy in lab settings and approximately 73% in everyday use.

Third is NeuroFit, a neurofeedback training suite. The N1 includes several cognitive training apps that use real-time EEG feedback to help users sharpen focus and improve sleep quality. Neuralink cited a clinical study led by Stanford's Department of Neurosciences showing that eight weeks of consistent NeuroFit use improved participants' sustained attention span by an average of 19%.

Ecosystem and Partnerships

At launch, the N1 supports both iOS and Android. Neuralink also released NeuralSDK for third-party developers. Unity and Epic Games announced native N1 input support in their game engines. Meditation app Calm and productivity tool Forest also confirmed N1 integration plans.

A statement from Meta Reality Labs' VP following the event noted that Meta is in discussions with Neuralink about deep integration of the N1 with the Quest line of VR headsets.

Risks and Controversies

The N1's consumer debut has sparked widespread debate. Jackie Feng, a neuroethics professor at UC Berkeley, said in an interview: "When a company can continuously read a consumer's brain activity data, where does the boundary of data privacy lie? EEG data is the most intimate form of biological information — it can reveal political leanings, sexual orientation, even subconscious thoughts you haven't recognized yourself."

Neuralink responded that all raw EEG data is processed locally on the N2 chip and never uploaded to the cloud. Users may opt in to share anonymized behavioral data for algorithm improvement and can delete it at any time. Critics, however, point out that whether "anonymized" EEG data is truly non-identifiable lacks independent third-party verification.

Another concern is long-term safety. Although the N1 is non-invasive, whether sustained electrical stimulation (used in feedback training) could have unknown effects on neuroplasticity remains unclear — no study has tracked users beyond six months. The U.S. FDA classifies the N1 as a Class II medical device (low-to-moderate risk) and requires Neuralink to continue collecting post-market safety data.

Market Outlook

The N1 is available for pre-order on Neuralink's website and at Best Buy, with first shipments expected in January 2028. Neuralink CEO Elon Musk closed the event by stating the company's goal of reaching 10 million N1 users within three years.

The $399 price tag came in below the industry's earlier $599 projection, placing it in the same range as AirPods Max and Sony's WH-1000XM6. Analysts view this as a deliberate positioning of the N1 as an everyday wearable rather than a high-end tech novelty.

Competition in the consumer BCI market is intensifying. Kernel, NextMind (acquired by Snap), and China's Naolu Technology are all developing similar products. Whether the N1 can fulfill Neuralink's vision of becoming "the next-generation human-computer interface" will face its real market test in 2028.